<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0017182"><a href="http://purl.obolibrary.org/obo/MONDO_0017182">MONDO:0017182</a></h3>
<p><strong>Label:</strong> familial hyperinsulinism</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0011153">MONDO:0011153</a> (hyperinsulinemic hypoglycemia, familial, 2), <a href="http://purl.obolibrary.org/obo/MONDO_0009278">MONDO:0009278</a> (hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0019265">MONDO:0019265</a> (Diazoxide-resistant focal hyperinsulinism), <a href="http://purl.obolibrary.org/obo/MONDO_0019010">MONDO:0019010</a> (congenital isolated hyperinsulinism), <a href="http://purl.obolibrary.org/obo/MONDO_0017186">MONDO:0017186</a> (Diazoxide-resistant hyperinsulinism), <a href="http://purl.obolibrary.org/obo/MONDO_0015624">MONDO:0015624</a> (Diazoxide-sensitive diffuse hyperinsulinism), <a href="http://purl.obolibrary.org/obo/MONDO_0015625">MONDO:0015625</a> (Diazoxide-resistant diffuse hyperinsulinism),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_79644">Orphanet:79644</a>, <a href="http://www.orpha.net/ORDO/Orphanet_165985">Orphanet:165985</a>, <a href="http://www.orpha.net/ORDO/Orphanet_276603">Orphanet:276603</a>, <a href="http://purl.obolibrary.org/obo/OMIM_231530">OMIM:231530</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601820">OMIM:601820</a>, <a href="http://www.orpha.net/ORDO/Orphanet_165988">Orphanet:165988</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609975">OMIM:609975</a>, <a href="http://www.orpha.net/ORDO/Orphanet_71212">Orphanet:71212</a>, <a href="http://www.orpha.net/ORDO/Orphanet_657">Orphanet:657</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79298">Orphanet:79298</a>, <a href="http://www.orpha.net/ORDO/Orphanet_276585">Orphanet:276585</a>, <a href="http://www.orpha.net/ORDO/Orphanet_276580">Orphanet:276580</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and <a href="http://purl.obolibrary.org/obo/HP_0040215">HP:0040215</a> (Abnormal circulating insulin level) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and <a href="http://purl.obolibrary.org/obo/HP_0040214">HP:0040214</a> (Abnormal insulin level) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003117">HP:0003117</a> (Abnormality of circulating hormone level) and <a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000842">HP:0000842</a> (Hyperinsulinemia) and <a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000825">HP:0000825</a> (Hyperinsulinemic hypoglycemia) and <a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0410030">HP:0410030</a> (Cleft lip))) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0200006">HP:0200006</a> (Slanting of the palpebral fissure))) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100886">HP:0100886</a> (Abnormality of globe location))) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100790">HP:0100790</a> (Hernia))) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system))) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0045060">HP:0045060</a> (Aplasia/hypoplasia involving bones of the extremities))) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0040069">HP:0040069</a> (Abnormality of lower limb bone))) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0040068">HP:0040068</a> (Abnormality of limb bone))) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0040064">HP:0040064</a> (Abnormality of limbs))) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004510">HP:0004510</a> (Pancreatic islet-cell hyperplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0031093">HP:0031093</a> (Abnormal breast morphology))) 47.86%</li>
</ul>
</body>
</html>
